Annual Operating Profit
-$8.83 M
+$1.71 M+16.19%
31 December 2023
Summary:
Monopar Therapeutics annual operaing income is currently -$8.83 million, with the most recent change of +$1.71 million (+16.19%) on 31 December 2023. During the last 3 years, it has fallen by -$2.32 million (-35.68%). MNPR annual operating profit is now -640.38% below its all-time high of -$1.19 million, reached on 31 December 2016.MNPR Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$1.57 M
+$213.90 K+11.96%
30 September 2024
Summary:
Monopar Therapeutics quarterly operating income is currently -$1.57 million, with the most recent change of +$213.90 thousand (+11.96%) on 30 September 2024. Over the past year, it has increased by +$491.10 thousand (+23.77%). MNPR quarterly operating profit is now -321.32% below its all-time high of -$373.80 thousand, reached on 31 March 2017.MNPR Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$7.00 M
+$491.10 K+6.56%
30 September 2024
Summary:
Monopar Therapeutics TTM operating income is currently -$7.00 million, with the most recent change of +$491.10 thousand (+6.56%) on 30 September 2024. Over the past year, it has increased by +$2.83 million (+28.79%). MNPR TTM operating profit is now -1772.42% below its all-time high of -$373.80 thousand, reached on 31 March 2017.MNPR TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MNPR Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.2% | +23.8% | +28.8% |
| 3 y3 years | -35.7% | +36.0% | +19.6% |
| 5 y5 years | -165.1% | -107.4% | -73.9% |
MNPR Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -35.7% | +16.2% | at high | +45.9% | at high | +34.0% |
| 5 y | 5 years | -165.1% | +16.2% | -107.4% | +45.9% | -73.9% | +34.0% |
| alltime | all time | -640.4% | +46.8% | -321.3% | +89.4% | -1772.4% | +59.7% |
Monopar Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.57 M(-12.0%) | -$7.00 M(-6.6%) |
| June 2024 | - | -$1.79 M(+3.8%) | -$7.49 M(-6.7%) |
| Mar 2024 | - | -$1.72 M(-9.9%) | -$8.03 M(-9.1%) |
| Dec 2023 | -$8.83 M(-16.2%) | -$1.91 M(-7.5%) | -$8.83 M(-10.1%) |
| Sept 2023 | - | -$2.07 M(-11.3%) | -$9.83 M(-3.4%) |
| June 2023 | - | -$2.33 M(-7.8%) | -$10.17 M(-4.1%) |
| Mar 2023 | - | -$2.52 M(-13.2%) | -$10.60 M(+0.6%) |
| Dec 2022 | -$10.54 M(+15.4%) | -$2.91 M(+20.8%) | -$10.54 M(+2.2%) |
| Sept 2022 | - | -$2.41 M(-12.9%) | -$10.31 M(-0.5%) |
| June 2022 | - | -$2.76 M(+12.5%) | -$10.36 M(+6.9%) |
| Mar 2022 | - | -$2.46 M(-8.4%) | -$9.69 M(+6.2%) |
| Dec 2021 | -$9.13 M(+40.2%) | -$2.68 M(+9.0%) | -$9.13 M(+4.8%) |
| Sept 2021 | - | -$2.46 M(+17.5%) | -$8.71 M(+10.3%) |
| June 2021 | - | -$2.09 M(+10.4%) | -$7.90 M(+8.6%) |
| Mar 2021 | - | -$1.89 M(-16.2%) | -$7.27 M(+11.7%) |
| Dec 2020 | -$6.51 M | -$2.26 M(+37.2%) | -$6.51 M(+18.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$1.65 M(+12.6%) | -$5.47 M(+19.4%) |
| June 2020 | - | -$1.46 M(+28.9%) | -$4.58 M(+13.1%) |
| Mar 2020 | - | -$1.14 M(-7.3%) | -$4.05 M(-6.3%) |
| Dec 2019 | -$4.32 M(+29.8%) | -$1.22 M(+61.3%) | -$4.32 M(+7.4%) |
| Sept 2019 | - | -$759.40 K(-18.5%) | -$4.03 M(+2.3%) |
| June 2019 | - | -$932.10 K(-33.8%) | -$3.93 M(+2.4%) |
| Mar 2019 | - | -$1.41 M(+51.9%) | -$3.84 M(+15.3%) |
| Dec 2018 | -$3.33 M(-79.9%) | -$926.40 K(+38.8%) | -$3.33 M(+6.0%) |
| Sept 2018 | - | -$667.50 K(-20.5%) | -$3.14 M(-81.9%) |
| June 2018 | - | -$840.00 K(-6.4%) | -$17.37 M(+1.4%) |
| Mar 2018 | - | -$897.30 K(+21.8%) | -$17.13 M(+3.2%) |
| Dec 2017 | -$16.60 M(+1291.9%) | -$736.80 K(-95.1%) | -$16.60 M(+4.6%) |
| Sept 2017 | - | -$14.90 M(+2403.8%) | -$15.87 M(+1537.7%) |
| June 2017 | - | -$595.00 K(+59.2%) | -$968.80 K(+159.2%) |
| Mar 2017 | - | -$373.80 K | -$373.80 K |
| Dec 2016 | -$1.19 M | - | - |
FAQ
- What is Monopar Therapeutics annual operaing income?
- What is the all time high annual operating profit for Monopar Therapeutics?
- What is Monopar Therapeutics annual operating profit year-on-year change?
- What is Monopar Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Monopar Therapeutics?
- What is Monopar Therapeutics quarterly operating profit year-on-year change?
- What is Monopar Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Monopar Therapeutics?
- What is Monopar Therapeutics TTM operating profit year-on-year change?
What is Monopar Therapeutics annual operaing income?
The current annual operating profit of MNPR is -$8.83 M
What is the all time high annual operating profit for Monopar Therapeutics?
Monopar Therapeutics all-time high annual operaing income is -$1.19 M
What is Monopar Therapeutics annual operating profit year-on-year change?
Over the past year, MNPR annual operaing income has changed by +$1.71 M (+16.19%)
What is Monopar Therapeutics quarterly operating income?
The current quarterly operating profit of MNPR is -$1.57 M
What is the all time high quarterly operating profit for Monopar Therapeutics?
Monopar Therapeutics all-time high quarterly operating income is -$373.80 K
What is Monopar Therapeutics quarterly operating profit year-on-year change?
Over the past year, MNPR quarterly operating income has changed by +$491.10 K (+23.77%)
What is Monopar Therapeutics TTM operating income?
The current TTM operating profit of MNPR is -$7.00 M
What is the all time high TTM operating profit for Monopar Therapeutics?
Monopar Therapeutics all-time high TTM operating income is -$373.80 K
What is Monopar Therapeutics TTM operating profit year-on-year change?
Over the past year, MNPR TTM operating income has changed by +$2.83 M (+28.79%)